Activation-induced cytidine deaminase (AID) initiates somatic hypermutation (SHM) and class switch recombination (CSR) in B lymphocytes by catalyzing the introduction of deoxyuracil: deoxyguanine mismatches into the DNA of the transcribed Ig locus. Repair pathways then process these mismatches to produce point mutations in the Ig variable region or double-stranded DNA breaks in the switch region followed by deletional recombination. It has been suggested that post-translational modifications on AID mediate a number of these different decisions, ranging from global targeting (Ig vs the genome), local targeting (variable vs switch region; transcribed vs non-transcribed strand) as well as process-appropriate DNA repair. Here we demonstrate that absence of RNF126, an E3 ligase shown to mono-ubiquitylate AID, results in a specific strand targeting defect in SHM, producing substantial G>C bias; strickingly, loss of RNF126 was also associated with tandem indels within the variable region (JH4 intron) but only a slight increase in the types of chromosomal translocations that are characteristic of deregulated AID. Conversely, these findings suggest that mono-ubiquitination of AID, likely in situ, is necessary for the proper removal of the protein from the non-transcribed strand, thus producing both optimal patterns of SHM and also limiting the number of indels within the target locus.
Introduction
Antibodies are initially assembled in the bone marrow in an antigen-independent manner by site-specific recombination (mediated by the RAG1/2 recombinase) and are further diversified in the secondary lymphoid organs through somatic hypermutation (SHM) and class switch recombination (CSR). SHM alters antibody affinity by introducing nucleotide changes in the antigen-binding variable region of antibodies. B cells producing antibodies with improved antigen affinity are positively selected during the process of affinity maturation 1 . CSR is a region-specific recombination reaction that replaces one antibody-constant region with another, thereby altering antibody effector function while leaving the variable region and its antigen binding specificity intact 1 .
While CSR and SHM are very different reactions, both are initiated by activationinduced cytidine deaminase (AID) 2, 3 , which introduces programmed DNA damage (a deoxyuracil-deoxyguanine (dU:dG) mismatch) at the Ig locus 4 .
Even though the vast majority of AID activity is sequestered to the Ig loci, AID can also induce "off-target" DNA damage, including point mutations in oncogenes such as bcl6 5 , as well as double-stranded breaks that result in oncogenic chromosome translocations such as those between c-myc and IgH (c-myc/IgH) 6 . Thus, maintaining genomic integrity requires strict control of AID activity and localization; this is achieved at transcriptional, post-transcriptional as well as post-translational levels.
Post-translationally, AID activity is regulated by phosphorylation and ubiquitination 7, 8 . To date, biochemical experiments have demonstrated that phosphorylation of certain residues (e.g. at Ser38 or Thr140) positively regulates AID activity whereas phosphorylation of others (e.g. Ser3) act to suppress AID activity.
However, most of these modifications are initially assessed with regard to their effect on CSR; their effect on SHM is deduced from experimental systems (DT40 gene conversion, mutation in 3T3-NTZ fibroblasts) that are not fully faithful to hypermutation at the Ig locus 8 .
Here, we focus on AID mono-ubiquitylation, which was first observed in nuclei of mutating cell lines (BL2) as well as nuclei of switching cells 7 . Using a protein-protein interaction screen, we had previously isolated the E3 ligase RNF126 and demonstrated that it selectively modified (mono-ubiquitylated) AID in vitro and in vivo (in HEK293T cells) 9 . To assess the effect of AID ubiquitylation within the relevant cell types, we examined aspects of CSR and SHM in B cells that were generated to conditionally lack the RNF126 E3 ligase. Our experiments demonstrate subtle but specific defects in the strand targeting of SHM in the absence of the modifying enzyme.
Results

Depletion of RNF126 from CH12F3 cells results in reduced CSR.
We have recently discovered that the RING E3 ligase RNF126, with E2 UbcH5b, can mono-ubiquitinate AID in cell-free assay conditions and in 293T cells 9 . To begin to assess the functional implications of RNF126-mediated AID ubiquitination, we turned to the CH12F3 cell line, an easily accessible model of CSR, thought to faithfully recapitulate the reaction 10 . CH12F3 cells express surface IgM, and can switch to surface IgA upon induction with proper stimulation (CD40, IL-4 and TGF-beta -10 ). They can also be infected with lentiviruses carrying shRNA hairpins: transfection of an shRNA that knocks down levels of AID protein leads to a near-complete ablation of CSR under these conditions ( Fig. 1A and 1B ). Transfection of shRNAs targeted to RNF126 result in diminished frequencies of CSR ( Fig. 1A and 1B) , commensurate with the levels of RNF126 protein remaining (Fig. 1C ). Hence, an acute knockdown of RNF126 from the CH12F3 cell line leads to a substantial reduction of switching from IgM to IgA (~70% reduction from WT levels, comparable to what has been reported for spt5 11 or ptbp2 12 ).
Conditional deletion of RNF126 from B cells results in mildly reduced CSR levels.
RNF126 is a relatively uncharacterized gene, and a full knock-out resulted in perinatal lethality and substantially skewed mendelian ratios ( Fig. S2A and not shown).
We thus generated an rnf126 -/conditional knock-out strain ( Fig. S1 ) which was crossed to mb1-Cre to achieve deletion of RNF126 early in B cell development 13 . Loss of RNF126 from the early B cell compartment onward, did not appear to affect B cell development in the bone marrow or levels of B cells in the spleen (Fig. S2 ).
We then sought to determine if primary B cells derived from RNF126 Fl/Fl mb1 Cre/+ mice displayed compromised levels of CSR. Specifically, we isolated splenocytes from these mice and stimulated them with IL-4/aCD-40 to induce a switch from IgM to IgG1.
In comparison to wildtype littermates, RNF126-deficient B cells are able to undergo CSR, but do so at consistently reduced frequencies, at every time point post stimulation ( Fig. 2A-B and Fig. 2D ). Recently, RNF126 has been proposed to support cancer cell proliferation by targeting p21 in cancer cell lines 14 and siRNA-mediated reduction of RNF126 levels was shown to result in loss of viability. Aside from a mild alteration in proliferation kinetics however ( Fig. 2C ), we did not observe increased cell death in these cultures (not shown). Thus, the loss of viability phenotype others have reported, might be restricted to tumour settings. AID protein is highly regulated at multiple levels and a mild reduction of CSR such as we observe (aggregated in Fig. 2D ) could result from alterations in protein amounts, subcellular localization or sub-nuclear targeting 1 . RNF126-deficient B cells do not display alterations in AID levels (in bulk - Fig. 2E ), and within these cells, AID can certainly enter the nucleus, and deaminate the switch region generating characteristic levels of Smu mutations ( Fig. 2F ), leading to initiation of appropriate DNA repair and resulting in CSR with near-wildtype kinetics.
Conditional deletion of RNF126 from B cells affects the processivity of AID on the
Ig locus.
CSR and SHM are both initiated by AID catalyzed deamination, yet the differences between them are substantial. Unlike CSR, an ex vivo or in vitro system that can faithfully recapitulate SHM does not exist currently and SHM is usually assessed by isolating B cells from germinal centers, and cloning and sequencing an intron within the Ig locus that is not the subject of selection (usually the JH4 intron).
To assess whether RNF126 deficiency affected SHM, we isolated CD19+GL7+Fas+ germinal center B cells from Peyers' patches excised from aged (9mo old) RNF126 Fl/Fl mb1 Cre/+ mice. From this material, we cloned and sequenced the JH4 intron and compared wildtype and RNF126-deficient cells for a number of SHM-related variables, such as the local base targeting preference of AID within the Ig locus, the strand biased targeting or repair of AID-mediated lesions, and ultimately, the efficiency of SHM (both in terms of frequency overall, and in terms of mutations per clone).
We found that mutation frequencies were overall slightly lower in the RNF126-/cells compared to their wildtype littermates (1 vs 1.5%). However, from RNF126-/-B cells we recovered a larger number of clones that were highly mutated (>10 mutations) as compared to the wildtype ( Figure 3A , p=0.008; one-tailed Fisher's exact test). This was both true for JH4 regions amplified from GC B cells isolated from Peyer's patches, and for JH4 regions amplified from GC B cells after immunization with NP-CGG (supplemental Fig. 3 ). These findings imply that when RNF126 is not present, unmodified AID stays on the locus longer.
SHM has also been associated with a low but measurable rate of insertions and deletions which account for 5-10% of all events, depending on the study 15 . Although usually quite short, indels can be of a variety of sizes 16 , and are thought to be the outcome of point mutations on opposite strands that occur sufficiently closely in space and time that they result in a DNA double strand break. They are also thought to be proximal measures of AID activity: AID overexpression leads to an increase in indel rates from about 5% to 25% 17 . We therefore sought to measure the numbers of clones with indels in our experiments, and found that the rates are very similar between RNF126-deficient animals and their wildtype littermates (~8%). This supports the notion that the encounter of AID with the Ig locus is not perturbed in the RNF126-/-B cells. But whereas the frequency of clones with indels is not different between the strains, the nature of indels, is. Specifically, whereas in wildtype B cells clones with indels contain a single indel event (confirming prior studies - 16, 17 ), we recovered a number clones with more than one, and sometimes up to three distinct indels per clone (accounting for 30% of clones with indels in the conditional knockout cells - Fig. 3B ). Together with the increase in numbers of mutations per mutated clone we noted in RNF126-/-B cells ( Fig.   3A ), this finding suggests a higher half life of unmodified AID on the locus. Specifically, a presumed loss of ability to be removed from DNA in a timely fashion, would be predicted to impact the apparent processivity of AID (both with regard to mutations per clone and with regard to the sequential indels in mutated clones) such as we observe.
Conditional deletion of RNF126 from B cells results in altered patterns of SHM.
AID displays local sequence preference for certain "hotspot" motifs in DNA, and because this preference is substantially similar in vivo and in vitro, it is thought that it is an inherent biochemical attribute of the molecule. This preference in hotspot targeting (e.g preference to deaminate the C residues in WRC (W = A or T, R = A or G) hotspot motifs) was not altered between wildtype and RNF126 deficient cells (not shown).
In vivo, the rate of mutation recorded from the non-transcribed strand, is equal from C or G (a C on the transcribed strand), suggesting that AID deaminates both substrate DNA strands equally well, during SHM 18, 19 . Indeed, it appears that AID induces dUs equally on both strands of the DNA 20 . In contrast to the equivalence of mutations from C or G, that are taken as evidence for balanced AID targeting, adenine (A) bases are mutated twice as frequently as the complementary thymine (T) bases.
This has been directly linked to the type of DNA repair recruited to the locus, and specifically, to the function of the TLS polymerase pol-eta, a low fidelity polymerase that preferentially synthesizes mispairs when copying T bases located on the transcribed strand 21, 22 , together with a number of DNA repair proteins that are normally part of the error-free mismatch repair complex 23 .
The A>T bias was largely intact in the RNF126-deficient B cells, suggesting that the presumed lack of AID modification did not alter the recruitment of the "canonical" error-prone repair pathway that spreads mutation through the locus (Fig. 3C) .
Surprisingly however, we found a strong bias in mutations from C or G as recorded from the non-transcribed strand: that is, Cs on the template strand are mutated more frequently. Whereas in the wildtype SHM G=C, SHM in RNF126-/-B cells show a substantial preference for G>C ( Fig.3C ). This finding is recapitulated in data from JH4 amplification and sequencing deriving from germinal center B cells, which were sorted after immunization with NP-CGG (supplemental Fig. 3 ).
Together with the effects caused by the absence of RNF126 on AID processivity and on strand bias, aspects of the reaction that are thought to be proximal to the introduction of dU in DNA, these experiments suggest that RNF126-mediated modification of a factor very close to the initiation of the introduction of dU in DNA (likely AID) is necessary for optimal SHM.
Conditional deletion of RNF126 from B cells slightly increases the level of AIDmediated translocations from the Ig locus
Increasing the time of occupancy of AID on the Ig locus might be predicted to result in the types of reciprocal chromosomal translocations that, while rare in wildtype cells, are the hallmarks of a number of B cell tumours, most prominently B cell lymphomas. To test for this, we queried RNF126-/-cells for reciprocal translocations between the IgH and c-myc loci (Fig. 4A) , which occur between a rate of ~0.5 in 10 6 in the wildtype and which are substantially increased in cells that ectopically overexpress AID (~50 in 10 6 ) 24 or cells that are deficient in DNA repair (e.g. pol-Q; ~3 in 10 6 ) 25 . We compared B cells from mice that were RNF126-/-(3 biological replicates) to their wildtype littermates (4 biological replicates) and to cells mice that were doubly deficient (ie AID-/-RNF126-/-; 4 biological replicates). These cells were stimulated to undergo CSR, and were collected and processed for translocation assays 72hrs after stimulation. Doubly deficient cells showed no translocations whatsoever, of any type (data not shown), much as has been reported for AID deficient cells. We recovered one reciprocal translocation in ~4 million wildtype cells, on average, in all replicates (~0.25 in Fig. 4C ). Because AID is not overexpressed in these cells, which are also repair proficient, we conclude that the slightly increased translocation rates here reflect increased occupancy of AID on the bottom (transcribed) strand of the Ig locus (also reflected in the processivity of both mutations and indels that we observe) and the DNA repair pathways that are called upon to remove it.
Discussion
The single-strand DNA-specific cytidine deaminase activation-induced cytidine deaminase (AID) is essential for antibody diversification both through CSR and through SHM 2,3 . AID deaminates cytosines within the transcribed Ig loci, and the deaminated DNA engages proteins of ubiquitous repair pathways to generate DSBs (in the case of CSR) or to spread the mutation from the original dU:dG base pair to the surrounding area, creating stereotyped patterns of SHM that are required for efficient diversification of the antibody binding pocket 26 .
All aspects of AID biology are highly regulated, from its subcellular localization (cytoplasmic retention vs nuclear import and export), to its targeted deposition onto the Ig locus once in the nucleus 27 . Once at the Ig locus, AID is further targeted to the VDJ exon (for SHM) or the S region intron (for CSR) where it acts on either strand to generate programmed DNA damage in the form of deaminated cytosine, which then differentially resolved either into stereotypical mutational patterns that spread well beyond the original dU:dG mispair (as is the case for SHM) or into DNA DSBs (in the case of CSR). Conversely, mistargeting of AID activity or the resolution of AID lesions to non-Ig genes has been implicated in chromosomal translocations and pathogenesis of B cell lymphomas 28 . But despite intense efforts and a number of recent advances, the exact mechanism of AID targeting to the Ig, as well as the mechanisms by which it differentially attracts DNA repair factors, remain unclear.
AID is a relatively small protein (25kDa) so it was originally hypothesized that much of the regulation discussed above is mediated by post-translational modifications.
Indeed, AID is heavily modified: for example, it is phosphorylated at multiple residues 8, 29 and patterns of phosphorylation might be important to determine some of these functions (for example the absence of phosphorylation at specific residues can differentially affect SHM vs CSR 8 ). Here we have focused on AID ubiquitylation as mediated by the E3 ligase RNF126. We have previously shown that in vitro and in overexpression systems, RNF126 does mono-ubiquitylate AID with some selectivity 9 . In vivo, absence of RNF126 from B cells, especially in the context of SHM, results in increased processivity of both mutations and indels, and in differences in strand bias.
These however do not result in significant increases in the rates of translocation between the Ig and myc loci, suggesting that the effect we see on SHM in the absence of RNF126 are limited to AID on the Ig locus. Focusing on the mutation and indel data, these suggest either that the bottom strand is targeted at increased rates (which then ought to result in alterations in the spreading of mutation to neighboring A/T bases, unlike what we observe) or, that AID must be actively removed from DNA, and that optimally, active removal from the locus requires modification in situ, either prior to, or concurrently with deamination of dC to dU.
The introduction of strand-balanced, AID-generated dU in DNA can result from at least three mechanisms. First, a biophysical, movement-related mechanism where negative supercoiling is generated on DNA on the wake of the RNA polymerase, dynamically generating short stretches of quasi-stable ssDNA on both strands 30, 31 .
Second, a mechanism that requires stalling of a transcription complex, with AID directly attacking the non-transcribed strand as well as the template strand after the exosomemediated "peeling" of RNA off the latter (this is likely the predominant mechanism in CSR - 32 ). Third, a transcription-complex-directed mechanism, where AID directly attacks the non-template ssDNA presented on the RNA polymerase during transcription, while attack on the template strand DNA requires a subsequent antisense transcription event 33 . Of these, the latter would predict that the AID-mediated initial deamination of dC to dU on both strands happens through an identical mechanism (attack on the non-template strand) but during two distinct waves of transcription: through deamination at non-template dC, with subsequent deamination at non-template dC on the opposite strand (recorded as dG on the top strand). Thus, the overall equivalence of mutations from C or G, would not necessarily imply that both strands are handled similarly, regarding the resolution of dU:dG into a mutation.
In vitro, AID displays remarkably high affinity for single-stranded DNA as indicated by the low dissociation constants and long half-life of complex dissociation 34 , and these biochemical findings have been taken to suggest that AID protein may persist the Ig locus after deamination, possibly acting as a scaffolding protein to recruit other factors. Given our in vivo data, we wondered whether the G>C strand imbalance we see, might be reflective of equivalent targeting of both strands, but an inability to properly remove AID from the template strand, unless it is modified. Essentially, we wondered whether ubiquitylation might be a "handle" with which a "mutasome" complex might remove AID from the locus, to allow for timely DNA repair so that transcription can proceed. In the absence of ubiquitylated AID then, the cell might resort to a salvage pathway of AID removal through DNA repair mechanisms that normally deal with DNA:protein adducts. Such mechanisms would include CtIP involvement, or involvement of the Mre11-Rad51-Nbs1 (MRN) complex. Both of these have been shown to act on the locus 35, 36 , and the MRN complex has been specifically associated with repair of template strand C 37 .
In contrast to SHM, CSR in RNF126-/-B cells is only mildly impacted ( Figure 2 ). This is either because targeting of AID to the switch or variable regions happens through substantially different mechanics (e.g. semi-stable R-loop formation vs transient single stranded regions), or, because the targeted removal of AID from switch regions, such as we suggest, though still necessary for transcription to proceed, is not essential for every single binding event (given that the regions will be excised from the genome).
We have not, however, succeeded in demonstrating that ubiquitylated AID is present within the chromatin of the Ig locus. This is likely for technical reasons: AID levels are not high in GC B cells, most of the protein (~95%) resides in the cytoplasm and even within the nuclear fraction, a small amount can be found on chromatin 38 .
Coupled with the fact that existing anti-AID antibodies are suboptimal in their ability to immunoprecipitate and/or detect AID, and that anti-Ub antibodies are usually not able to detect mono-ubiquitylated protein species, at present, we cannot formally demonstrate that in the wildtype, AID is monoubiquitylated by RNF126 in situ. However, taken together, our data do suggest that monoubiquitylation of AID is necessary for optimal removal of the protein from DNA, allowing DNA repair factors to access the dUcontaining strand in a timely fashion so that transcription can proceed. graduate fellowships from the National Defense Science and Engineering Foundation and the National Science Foundation (to RKD) and by a postdoctoral fellowship from the Beckman Foundation (to PS).
Contributions
The RNF126 conditional mouse was originally generated and initially characterized by 
